Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression
出版年份 2019 全文链接
标题
Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression
作者
关键词
-
出版物
Cancers
Volume 12, Issue 1, Pages 57
出版商
MDPI AG
发表日期
2019-12-24
DOI
10.3390/cancers12010057
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?
- (2019) Virginie Lemiale et al. Annals of Intensive Care
- PD-1-siRNA delivered by attenuated Salmonella enhances the antimelanoma effect of pimozide
- (2019) Tiesuo Zhao et al. Cell Death & Disease
- Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy
- (2019) Kang Liang et al. CANCER LETTERS
- PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer
- (2019) Reem Saleh et al. Cancers
- Efficacy of Tumor-Targeting Salmonella typhimurium A1-R against Malignancies in Patient-Derived Orthotopic Xenograft (PDOX) Murine Models
- (2019) Takashi Murakami et al. Cells
- Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales
- (2019) Li Fan et al. CANCER LETTERS
- STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
- (2019) Zerdes et al. Cancers
- Bacteriotherapy in Breast Cancer
- (2019) Atieh Yaghoubi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Salmonella mediated cytolethal distending toxin transfer inhibits tumor growth
- (2018) Wei-Kuang Wang et al. HUMAN GENE THERAPY
- A Nonpyroptotic IFN-γ–Triggered Cell Death Mechanism in Nonphagocytic Cells PromotesSalmonellaClearance In Vivo
- (2018) Justin P. Ingram et al. JOURNAL OF IMMUNOLOGY
- The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells
- (2018) Yue Zou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression
- (2018) Xin Jin et al. MOLECULAR CELL
- Exploiting the cancer niche: Tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy
- (2017) Vera L. Silva et al. JOURNAL OF CONTROLLED RELEASE
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Tumor-specific cell-cycle decoy bySalmonella typhimuriumA1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging
- (2016) Shuya Yano et al. CELL CYCLE
- Salmonella inhibits tumor angiogenesis by downregulation of vascular endothelial growth factor
- (2016) Dom-Gene Tu et al. Oncotarget
- Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction
- (2016) Djoke Hendriks et al. OncoImmunology
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Salmonella overcomes tumor immune tolerance by inhibition of tumor indoleamine 2, 3-dioxygenase 1 expression
- (2015) Yu-Diao Kuan et al. Oncotarget
- Immunologic and Clinical Effects of Targeting PD-1 in Lung Cancer
- (2014) R D Harvey CLINICAL PHARMACOLOGY & THERAPEUTICS
- Salmonella as an Innovative Therapeutic Antitumor Agent
- (2014) Wen-Wei Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NFATc1 Regulates PD-1 Expression upon T Cell Activation
- (2014) K. J. Oestreich et al. JOURNAL OF IMMUNOLOGY
- The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity
- (2014) Suzanne Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer
- (2012) Andreas G Niethammer et al. BMC CANCER
- Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
- (2012) Esdy N. Rozali et al. Clinical & Developmental Immunology
- Scutellaria barbatainhibits angiogenesis through downregulation of HIF-1 α in lung tumor
- (2012) Ai-Li Shiau et al. ENVIRONMENTAL TOXICOLOGY
- T cell augments the antitumor activity of tumor-targeting Salmonella
- (2011) Che-Hsin Lee et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Toll-like Receptor 4 Mediates an Antitumor Host Response Induced by Salmonella choleraesuis
- (2008) C.-H. Lee et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started